Similar articles

• Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.

  Knoll K, Wrasidlo W, Scherberich JE, Gaedicke G, Fischer P. Knoll K, et al. Cancer Res. 2000 Nov 1;60(21):6089-94. Cancer Res. 2000. PMID: 11085532
• Immunohistochemical differentiation of metastases of renal carcinomas versus other carcinomas with anti-gamma GT monoclonal antibody 138H11.

  Kaufmann O, Dietel M, Scherberich JE, Gaedicke G, Fischer P. Kaufmann O, et al. Histopathology. 1997 Jul;31(1):31-7. doi: 10.1046/j.1365-2559.1997.5800813.x. Histopathology. 1997. PMID: 9253622
• Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.

  Fischer P, Baum RP, Tauber M, Boeckmann W, Weier S, Scherberich JE. Fischer P, et al. Cancer Immunol Immunother. 1992;35(4):283-8. doi: 10.1007/BF01789336. Cancer Immunol Immunother. 1992. PMID: 1355011 Free PMC article.
• The enediyne antibiotics.

  Smith AL, Nicolaou KC. Smith AL, et al. J Med Chem. 1996 May 24;39(11):2103-17. doi: 10.1021/jm9600398. J Med Chem. 1996. PMID: 8667354 Review. No abstract available.
• Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin.

  Dedon PC, Goldberg IH. Dedon PC, et al. Chem Res Toxicol. 1992 May-Jun;5(3):311-32. doi: 10.1021/tx00027a001. Chem Res Toxicol. 1992. PMID: 1380322 Review. No abstract available.